Inhibiting retinoic acid signaling ameliorates graft-versus-host disease by modifying T-cell differentiation and intestinal migration.

MLA

Aoyama, Kazutoshi, et al. “Inhibiting Retinoic Acid Signaling Ameliorates Graft-versus-Host Disease by Modifying T-Cell Differentiation and Intestinal Migration.” Blood, vol. 122, no. 12, Sept. 2013, pp. 2125–34. EBSCOhost, https://doi.org/10.1182/blood-2012-11-470252.

APA

Aoyama, K., Saha, A., Tolar, J., Riddle, M. J., Veenstra, R. G., Taylor, P. A., Blomhoff, R., Panoskaltsis-Mortari, A., Klebanoff, C. A., Socié, G., Munn, D. H., Murphy, W. J., Serody, J. S., Fulton, L. M., Teshima, T., Chandraratna, R. A., Dmitrovsky, E., Guo, Y., Noelle, R. J., & Blazar, B. R. (2013). Inhibiting retinoic acid signaling ameliorates graft-versus-host disease by modifying T-cell differentiation and intestinal migration. Blood, 122(12), 2125–2134. https://doi.org/10.1182/blood-2012-11-470252

Chicago

Aoyama, Kazutoshi, Asim Saha, Jakub Tolar, Megan J Riddle, Rachelle G Veenstra, Patricia A Taylor, Rune Blomhoff, et al. 2013. “Inhibiting Retinoic Acid Signaling Ameliorates Graft-versus-Host Disease by Modifying T-Cell Differentiation and Intestinal Migration.” Blood 122 (12): 2125–34. doi:10.1182/blood-2012-11-470252.